DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Avience Biomedicals Limited — Board Meeting Intimation

NSE 3 hrs ago·2 Sept 2026, 9:56 am

AVIENCE NSE

Avience Biomedicals has announced that its board will meet on September 7, 2026, to discuss 'other business'. This is a standard corporate procedure that allows a company to consider matters beyond its regular agenda, such as mergers, acquisitions, or significant strategic partnerships.

For investors, this is a neutral update that signals the company is actively evaluating potential growth opportunities. It does not confirm any specific action, but it keeps the stock on the radar for those tracking the company's strategic direction.

Investors should wait for the official announcement following the meeting to understand the nature of the 'other business' and its potential impact on the company's future.